Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study - Concepedia

Concepedia

Publication | Open Access

Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study

DOI Full Paper Access

35

Citations

24

References

2021

Year

Akshay Gupte, Pavan Kumar, Mariana Araújo‐Pereira, Vandana Kulkarni, Mandar Paradkar, Neeta Pradhan, Pradeep A. Menon, Chandrasekaran Padmapriyadarsini, Luke-Elizabeth Hanna, Shri Vijay Bala Yogendra Shivakumar,

European Respiratory Journal

Abstract

Pre-treatment IL-6 is a biomarker for unfavourable TB treatment outcomes. Future studies should identify optimal IL-6 concentrations for point-of-care risk prediction.

References

	Year	Citations

Page 1